Category Archives: Taunia Markvicka

Geothermal Technology Benefits Homeowners

Geothermal Technology pic
Geothermal Technology
Image: epa.gov

With more than 20 years of experience in various aspects of the pharmaceutical industry, Taunia Markvicka recently served as the chief commercial officer of Symbiomix Therapeutics, and various commercial leadership roles formerly at Pacira Pharmaceuticals, The Medicines Company, Allergan, and Novartis. In her most recent position, she provided market analysis, strategic planning, and company leadership to support funding, strategic partners for the pharmaceutical company, and commercial leadership for FDA approval for their lead asset, Solosec. Taunia Markvicka and her family are involved in a variety of environmental causes and have determined to live a lifestyle that embraces responsible stewardship of their energy consumption. Accordingly, they have installed a geothermal heating system into their home in New Jersey.

Widely acknowledged as the greenest, most efficient, and cost-effective heating and cooling system on the market, geothermal systems can help homes maintain a consistent temperature throughout the year. The technology is widely used in China, Sweden, New Zealand, and Iceland but has been slow to gain popularity in the United States.

Since tax credits are often available for renewable energy installations, advocates of geothermal heating and cooling hope that more American homes will embrace the systems. Many homeowners have found that they can save up to 70 percent on their heating and cooling costs with the long-term use of geothermal systems.

Advertisements

How to Stand up on a Paddleboard

 

Healthcare Businesswomen’s Association Names 2018 Woman of the Year

 

Healthcare Businesswomen's Association pic
Healthcare Businesswomen’s Association
Image: hbanet.org

Taunia Markvicka, with a doctor of pharmacy and MBA, has spent more than two decades in leadership roles with pharmaceutical companies throughout New Jersey. Similar to the 2018 Woman of the Year, Taunia Markvicka belongs to professional organizations such as the Healthcare Businesswomen’s Association (HBA), supporting public advocacy, and working on medicines for the most common gynecologic infection. Dr. Markvicka, actively participates and support organizations that provide leadership development for women in healthcare.

Formed more than 40 years ago in the northeastern United States, the HBA has evolved into one of the most prominent global nonprofit organizations devoted to the support and professional development of women in the healthcare field. The organization currently serves more than 9,000 individual members through a combination of networking events, educational opportunities, and advocacy for gender equality in the healthcare professions.

To recognize distinguished members of the organization, the HBA maintains an annual awards program that honors outstanding mentors, rising stars in the field, and other accomplished women. The group’s most prestigious honor is its Woman of the Year award, given each year to a woman in the health care professions who consistently serves as an inspiration to her peers.

In 2018, the Woman of the Year award went to Dr. Julie Gerberding, an executive for Merck & Co., Inc. Dr. Gerberding was recognized for her longtime leadership in the public health community, including her guiding role in modernizing the Centers for Disease Control and Prevention (CDC) and her global reputation as one of the foremost experts on infectious disease and public health.

Bacterial Vaginosis – A Serious Health Concern for Women

 

Bacterial Vaginosis pic
Bacterial Vaginosis
Image: webmd.com

With over 30 years’ experience in pharmaceuticals, Taunia Markvicka serves as the chief commercial officer of Symbiomix Therapeutics in Newark, New Jersey. Taunia Markvicka has taken the lead in launching the company’s new product, Solosec.

Solosec has been approved for treatment of bacterial vaginosis (BV), a condition that affects some 21 million women ages 14-49. It is the most common gynecologic infection in that age group, and strikes women of color disproportionately.

The disease impairs the natural balance of lactobacilli (“good” bacteria) and anaerobic (“bad” bacteria) in the vagina, by producing too many of the anaerobic variety. Symptoms include a thin (gray, white, or green) discharge, a foul, fishy odor, itching, and burning while urinating.

BV has significant health consequences, such as an increased risk of sexually transmitted diseases (trichomoniasis, herpes, chlamydia, and gonorrhea), and untreated BV can lead to infertility. BV also increases the risk of premature birth. It can also lead to complications after gynecologic surgery. This diversity of risks, warrants greater education and research to improve health outcomes.

Risk factors for BV include multiple or new sex partners, same-sex relations among women, douching, and the absence of lactobacilli (“good”) bacteria.